Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – ARUP Laboratories will begin offering Decode Genetics' prostate cancer test in the fall under a deal announced today.

ARUP will offer Decode's ProstateCancer test to academic medical centers, public and private healthcare providers, and major hospitals in the US as part of its portfolio of tests. The test will be ordered through ARUP, which will handle patient samples and results. Decode will analyze the samples in its CAP and CLIA-certified laboratory.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.